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SCIENTIFIC OPINION 
Scientific Opinion on the safety and efficacy of Bacillus amyloliquefaciens 
(NCIMB 30229) as a silage feed additive for all species
1 
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP)
2,3 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
A  strain  of  Bacillus  amyloliquefaciens  is  intended  to  be  added  to  forages  to  promote  the  ensiling  process 
(technological additive, functional group: silage additive). The identity of the strain and its susceptibility to 
relevant antibiotics has been established. However, the strain produces cyclic lipopeptides which possess potent 
surfactant activity, known to be involved in food intoxication. Although the strain is intended for use only in the 
production of silage, as a spore former it will survive the ensiling process and be ingested by target animals. The 
spores  will  also  survive  passage  through  the  gastrointestinal  tract  of  animals  and  be  a  potential  source  of 
contamination of food of animal origin and of the environment. The greatest risk would be to those handling the 
product on farm following oral, dermal and respiratory exposure. Consequently, the FEEDAP Panel concludes 
that use of the strain in the production of silage presents a hazard to consumers, users and the environment, and 
potentially also to the target animals. A total of three laboratory experiments with laboratory-scale silos, each 
lasting at least 90 days, were carried out using samples of forage of differing dry matter and water-soluble 
carbohydrate content. In each case, replicate silos containing treated forage were compared with identical silos 
containing the same but untreated forage. The potential of the additive to improve aerobic stability of silages at 
the proposed dose of 5.0   10
7 CFU/kg fresh materials was not convincingly demonstrated. 
© European Food Safety Authority, 2013 
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SUMMARY 
Following a request from the European Commission, the Panel on Additives, Products or Substances 
used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on the safety for the target 
animals, consumer, user and the environment and on the efficacy of a product based on a single strain 
of Bacillus amyloliquefaciens, when used as a technological additive intended to improve the ensiling 
process at a proposed dose of 5   10
7 CFU/kg fresh material of easy and moderately difficult to ensile 
forages. 
The identity of B. amyloliquefaciens NCIMB 30229 and its susceptibility to relevant antibiotics has 
been established. However, the strain produces cyclic lipopeptides which possess potent surfactant 
activity, known to be involved in food intoxication. Although the strain is intended for use only in the 
production of silage, as a spore former it will survive the ensiling process and be ingested by target 
animals. The spores will also survive passage through the gastrointestinal tract of animals and be a 
potential source of contamination of food of animal origin and of the environment. The greatest risk 
would be to those handling the product on farm. Consequently, the FEEDAP Panel concludes that use 
of the strain in the production of silage presents a hazard to consumers, users and the environment, and 
potentially also to the target animals. 
A total of three experiments with laboratory-scale silos, each lasting at least 90 days, were carried out 
using samples of forage of differing dry matter and water-soluble carbohydrate content. In each case, 
replicate silos containing treated forage were compared with identical silos containing the same but 
untreated forage. The potential of the additive to improve aerobic stability of silages at the proposed 
dose of 5.0   10
7 CFU/kg fresh material was not convincingly demonstrated. Bacillus amyloliquefaciens NCIMB 30229 for all species 
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BACKGROUND  
Regulation  (EC)  No  1831/2003
4  establishes the rules governing the Community authorisation of 
additives for use in animal nutrition. In particular Article 10(2)/(7) of that Regulation specifies that for 
existing products within the meaning of Article 10(1), an application shall be submitted in accordance 
with Article 7, within a maximum of seven years after the entry into force of this Regulation. 
The European Commission received a request from  SILAC-EEIG-Silage Additives
5  for  the  re-
evaluation of the product Bacillus amyloliquefaciens (NCIMB 30229) to be used as a feed additive for 
all  animal  species  (category:  technological  additive;  functional  group:  silage  additive)  under  the 
conditions mentioned in Table 1.  
According  to  Article  7(1)  of  Regulation  (EC)  No  1831/2003,  the  Commission  forwarded  the 
application to the European Food Safety Authority (EFSA) as an application under Article 10(2)/(7) 
(re-evaluation of an authorised feed additive). EFSA received directly from the applicant the technical 
dossier in support of this application.
6 According to Article 8 of that Regulation, EFSA, after verifying 
the particulars and documents submitted by the applicant, shall undertake an assessment in order to 
determine whether the feed add itive complies with the conditions laid down in Article 5. The 
particulars and documents in support of the application were considered valid by EFSA as of  1 June 
2011. 
This product was included in the Community Register of Feed Additives following the prov isions of 
Article 10(1) of Regulation (EC) No 1831/2003. 
TERMS OF REFERENCE  
According to Article 8 of Regulation (EC) No 1831/2003, EFSA shall determine whether the feed 
additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on the 
safety for the target animals, consumer, user and the environment and the efficacy of the product 
Bacillus amyloliquefaciens (NCIMB 30229), when used under the conditions described in Table 1. 
                                                       
4  Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use 
in animal nutrition. OJ L 268, 18.10.2003, p. 29  
5  SILAC-EEIG-Silage Additives, Avenue Louise, 120-Box 13, 1050, Brussels, Belgium; Company: Micron Bio-System, 
UK. 
6  EFSA Dossier reference: FAD-2010-0192. Bacillus amyloliquefaciens NCIMB 30229 for all species 
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Table 1:  Description and conditions of use of the additive as proposed by the applicant 
Additive   Bacillus amyloliquefaciens MBS-BS-01 / NCIMB 30229 
Registration number/EC No/No 
  - 
Category(ies) of additive  Technological  
Functional group(s) of additive  Silage additive 
 
Description 
Composition, description  Chemical 
formula 
Purity criteria 
 
Method of analysis 
 
Preparation of Bacillus 
amyloliquefaciens (MBS-BS-01 / 
NCIMB 30229) having minimum 
activity of: 2.5 x 10
10 CFU/g 
Not appropriate 
Significant impurities: 
- Coliforms: <1000 
CFU/g 
- Yeast and molds: 
<1000 CFU/g 
 
Relevant impurities: 
- E. coli: <10 CFU/g 
- Salmonella: absence in 
25g 
- Aflatoxin B1: <1µg/kg 
Enumeration method 
EN 15784:2009 
 
Identification method 
(genetic): PFGE 
 
Trade name   Not appropriate 
Name  of  the  holder  of 
authorisation  
Not appropriate 
 
Conditions of use 
Species or 
category of 
animal 
Maximum Age 
Minimum content  Maximum content  Withdrawal 
period 
  CFU/kg of complete feedingstuffs  
All species 
and 
categories 
-  5 x 10
7 (easy and 
moderate)  -  Not appropriate 
 
Other provisions and additional requirements for the labelling 
Specific  conditions  or  restrictions 
for use  
In the direction for use indicate the storage temperature, and storage life.  
Specific  conditions  or  restrictions 
for handling   For safety: eye protection and gloves shall be used during handling 
Post-market monitoring  
(if appropriate) 
Not appropriate 
Specific  conditions  for  use  in 
complementary feedingstuffs  
 
Not appropriate 
 
Maximum Residue Limit (MRL)  
Marker residue  Species or category of 
animal 
Target tissue(s) or 
food products 
Maximum content 
in tissues 
Not appropriate  Not appropriate  Not appropriate  Not appropriate Bacillus amyloliquefaciens NCIMB 30229 for all species 
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ASSESSMENT 
1.  Introduction 
The present additive is based on a preparation of a single strain of Bacillus amyloliquefaciens and is 
intended to be added to forages to promote the ensiling process (technological additive, functional 
group:  silage  additive)  for  the  eventual  use  of  the  silage  in  any  animal  species.  The  species 
B. amyloliquefaciens is considered by the EFSA to be suitable for the Qualified Presumption of Safety 
(QPS) approach to safety assessment (EFSA, 2007, 2012a). This approach requires the identity of the 
strain to be conclusively established and evidence that the strain does not show acquired resistance to 
antibiotics  of  human  and  veterinary  importance  and  the  absence  of  toxigenic  potential  to  be 
demonstrated. 
2.  Characterisation 
2.1.  Identity and properties of the active agent 
The strain of B. amyloliquefaciens was isolated from hay and is deposited with the National Collection 
of Industrial and Marine Bacteria (NCIMB) with the accession number NCIMB 30229.
7 It has not 
been genetically modified. Strain identity was established by the full 16S rRNA gene sequence, which, 
by  comparison  with  sequences  recorded  in  databases ,  was  unamb iguously  identified  as 
B. amyloliquefaciens. Strain-specific identification and genetic stability analysis are based on the use 
of pulsed-field gel electrophoresis.
8 Using this method, the master culture is routinely compared with 
working cultures used to inoculate fermentation batches. No differences in the resultant patterns have 
been observed to date. 
The strain was tested for antibiotic susceptibility using two -fold broth dilutions. The battery of 
antibiotics tested was that recommended by  the  EFSA (EFSA,  2012b).
9  All minimum inhibitory 
concentration values for the B. amyloliquefaciens strain were equal to or fell below the corresponding 
cut-off values defined by the FEEDAP Panel. 
The  toxigenic  potential  of  B.  amyloliquefaciens  (NCIMB  30229)  was  assessed  following  the 
recommendation of the Technical Guidance on the assessment of the toxigenic potential of Bacillus 
species used in animal nutrition (EFSA, 2011).
10 Although the strain is not haemolytic on blood agar, a 
PCR-DNA sequencing approach, designed to detect non-ribosomal peptide synthase genes, has shown 
in B. amyloliquefaciens (NCIMB 30229) the presence of genes involved in the synthesis of the non-
ribosomal  peptides  surfactin,  fengycin  and  bacillomycin  (a  member  of  iturin  family).  A  mass 
spectrometry  analysis  (matrix-assisted  laser  desorption/ionisation  time  of  flight  (MALDI-TOF)), 
performed on a vegetative culture of B. amyloliquefaciens (NCIMB 30229), detected the peptides with 
a mass corresponding to surfactin or pumilacidin, fengycin, iturin A or mycosubtilin.  
2.2.  Production and characteristics of the additive  
The active agent is grown in a sterilised medium typical of those used for bacilli and then separated 
from  the  growth  medium  by  centrifugation.  The  spore  suspension  is  spray  dried  and  the  ground 
powder is then blended with sufficient carrier to meet the minimum specified concentration of 2   10
10 
CFU/g additive. The resultant additive consists of viable spores, fermentation media (<0.1 %) and 
carriers (lactose  28–68 % and  silica  2 %). Material safety  data  sheets  are  provided  for  all carrier 
materials,  all  of  which  are  of  food  grade  and  do  not  introduce  safety  concerns.
11  Data on five 
                                                       
7  Technical dossier/Section II/Annex II.2-6. 
8  Technical dossier/Section II/Annexes II.2-3 to 5. 
9  Technical dossier/Section II and Supplementary information July 12 /Annexes II.2-8 and Qi. 
10   Technical dossier/Section II and Supplementary information July 12 /Annexes II.2-7 and Qii. 
11   Technical dossier/Section II/Annexes II.3-4 to II.3-16. Bacillus amyloliquefaciens NCIMB 30229 for all species 
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production batches showed that the minimum specification was exceeded in all cases (mean 5.4   10
11 
CFU/g additive, coefficient of variation (CV) 3.7 %).
12 
Three batches of the additive were examined for particle size distribution by laser diffraction and for 
dusting potential using a Heubach dustometer.  Analysis showed that  22 % of the  particles have a 
diameter of less than 10 μm, 60 % a diameter of less than 50 μm and 78 % a diameter of less than 
100 μm. The dusting potential (11.9 g/m
3) is considered to be high.
13 
The additive is routinely monitored for microbial contamination at various points in the manufacturing 
process and in the final product. Limits are set for  Enterobacteriaceae and yeasts and filamentous 
fungi (<10
3 CFU/g additive), Escherichia coli (<10 CFU/g additive) and Salmonella spp. (absence in 
25 g of additive). Analyses of three batches confirmed compliance with the specifications.
14  
Given the nature of the fermentation medium and the food -grade excipients, the probability of 
contamination with heavy metals or mycotoxins is considered to be low and ,  consequently, such 
contamination is not routinely monitored. However, one batch of the additive was, analysed to confirm 
that this is the case, and the concentration of aflatoxin B1 concentration was in fact found to be lower 
than the limit set for action.
15 
2.3.  Stability 
The additive when stored in the original packaging is stable for one year at 20°C (or lower).
15  
2.4.  Conditions of use 
The additive is intended for use with forages at ensiling at a proposed minimum dose of 5 x 10
7 
CFU/kg fresh materials for the improvement of the aerobic stability in material of different botanical 
origin easy and moderately difficult to ensile. 
2.5.  Evaluation of the analytical methods by the  European Union Reference Laboratory 
(EURL) 
EFSA has verified the EURL report as it relates to the methods used for the control of the active agent 
in animal feed. The Executive Summary of the EURL report can be found in the Appendix. 
3.  Safety  
In  the  view  of  the  FEEDAP  Panel,  the  identity  of  the  bacterial  strain  under  application  and  its 
susceptibility to clinically relevant antibiotics have been established. However, B. amyloliquefaciens 
(NCIMB 30229) produces cyclic lipopeptides which possess potent surfactant activity and are known 
to exert toxicity on mammalian cells (From et al., 2007a, b; Hwang et al., 2009). Although the strain is 
intended for use only in the production of silage, as a spore former it will survive the ensiling process 
and be ingested by the target animals. The spores will also survive passage through the gastrointestinal 
tract  of  animals  and  be  a  potential  source  of  contamination  of  food  of  animal  origin  and  of  the 
environment. The greatest risk would be to those handling the product on farm following oral, dermal 
or respiratory exposure. In this context, it should be noted that the dusting potential of the commercial 
formulations tested was high.  
In  the  absence  of  data,  and  due  to  its  proteinaceous  nature,  the  additive  should  be  considered  a 
potential skin/eye irritant and skin/respiratory senisitiser. 
                                                       
12   Technical dossier/Section II/Annex II.1-5. 
13   Technical dossier/Section II/Annexes II.1-8 and 9. 
14   Technical dossier/Section II/Annexes II.1-6 and 7. 
15   Technical dossier/Section II/Annex II.4-1. Bacillus amyloliquefaciens NCIMB 30229 for all species 
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4.  Efficacy 
A total of three laboratory experiments with three different forage samples were performed, lasting at 
least 90 days. All studies were made using 60-L mini-silos, which were filled with the same weight of 
forage (17 kg) and compressed with 6 kg sand and a 29-kg steel disc. The mini-silo was fitted to give 
an air-tight seal. The contents of the four replicate silos were sprayed with the additive at 5   10
7 
CFU/kg forage dissolved in 34 mL water (dose not confirmed by analysis of the applied suspension). 
Forages for the four control silos were sprayed with an equal volume of water without the additive. 
Ambient temperature was 20 °C. 
The three studies involved a range of forages of different dry matter (24–31 % DM) and water-soluble 
carbohydrate  (WSC)  content  (see  Table  2).  The  samples  represented  material  easy  to  ensile 
(experiments 1 and 2) and moderately difficult to ensile (experiment 3) as defined by their WSC 
content. No samples of difficult to ensile material were included. 
Table 2:  Characteristics of forages prior to ensiling 
Study   Test material  Dry matter (%)  Water-soluble carbohydrate content 
(% fresh matter) 
1
16  Grass  30.8  5.5 
2
17  Grass  31.2  7.3 
3
18  Grass  23.7  2.5 
 
Replicate silos were opened at the end of the experiment and the contents were analysed for dry 
matter, pH, lactic acid, volatile and total fatty acids (VFA and TFA) concentrations, propanol, moulds 
and  presumptive  yeasts.  Aerobic  stability  was  also  followed  by  measurement  of  the  change  of 
temperature. In a separate sample per  replicate silo, temperature was continuously monitored for a 
period of seven days in studies 1 and 3, and for 16 days in study 2, at controlled temperature of 20 °C. 
Silage temperatures were averaged into two-hourly segments and a two-way  analysis of variance 
(ANOVA) using the generalised linear model (GLM) procedure was carried out. A corresponding 
ANOVA was applied to the data on silage quality.  
No significant differences  in  the silage quality parameters measured  were observed in any study 
(except sugars in study 3: 12 % in the control, 9.5 % in the treated silage). However, a tendency for 
reduced pH  (studies  2 and 3)  compared  with  control  and increased acetic acid concentration  (all 
studies) could be seen (Table 3). 
                                                       
16   Technical dossier/Section IV/Annex IV.1-2. 
17   Technical dossier/Section IV/Annex IV.1-3. 
18   Technical dossier/Section IV/Annex IV.1-1. Bacillus amyloliquefaciens NCIMB 30229 for all species 
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Table 3:  Summary of the analysis of ensiled material recovered at the end of the experiment  
Study no 
(duration, days) 
Dose 
(CFU/kg 
forage) 
Dry matter 
(%)  pH  Lactic acid  
(% DM) 
Acetic 
acid  
(% DM) 
Average  
temperature
1 
(°C)  
1 (99)  
0  31.8  3.7  7.0  1.2  24.4 
5   10
7  31.1
  3.9
  8.2
  1.9  23.7* 
2 (90)  
0  31.0  4.2  11.3  1.8  23.2 
5   10
7  28.8
  3.9
  11.9
  2.3  22.2* 
3 (99) 
0  25.8  4.0  10.7  2.1  22.6 
5   10
7  26.4
  3.9
  10.4
  2.7  21.2* 
1Days 1–7 of aerobic exposure in studies 1 and 3 and days 1–16 in study 2. 
*Significantly different from the control value at
 P < 0.01. 
 
The reports submitted by the applicant conclude, for all three studies, that the overall aerobic stability 
of  grass  silage  was  significantly  better  following  treatment  with  B.  amyloliquefaciens  (NCIMB 
30229).  However,  a  rise  of  3 °C  above  ambient  temperature,  required  by  Regulation  (EC)  No 
429/2008 as indicative of a loss of aerobic stability, was obtained 2.3 days (P = 0.08), 0.75 days 
(P = 0.45), and 2.9 days (P = 0.21) later in the treated than in the control samples in studies 1, 2 and 3, 
respectively. The thresholds of the above Regulation (evidence of stability for at least two days longer 
than that shown by untreated control) are only reached in studies 1 and 3. The considerable variability 
between replicates, particularly in studies 2 and 3, may have prevented significance (P < 0.05) in all 
studies.  
The mean temperature differences calculated for the total observation periods were likely to be driven 
by one (or two) replicates of the untreated samples. The data do not provide convincing evidence for 
the potential of B. amyloliquefaciens (NCIMB 30229) to improve the aerobic stability of silages. 
CONCLUSIONS  
The identity of Bacillus amyloliquefaciens (NCIMB 30229) and its susceptibility to clinically relevant 
antibiotics  has  been  established.  However,  the  strain  produces  cyclic  lipopeptides  which  possess 
potent surfactant activity, known to be involved in food intoxication. Although the strain is intended 
for use only in the production of silage, as a spore former it will survive the ensiling process and be 
ingested by the target animals. The spores will also survive passage through the gastrointestinal tract 
of animals and be a potential source of contamination of food of animal origin and of the environment. 
The greatest risk would be to those handling the product on farm. Consequently, the FEEDAP Panel 
concludes that use of the strain in the production of silage presents a hazard to consumers, users and 
environment, and potentially also to target animals. 
The potential of the additive to improve aerobic stability of silages at the proposed dose of 5.0   10
7 
CFU/kg fresh material (easy and moderately difficult to ensile forage species covering a range of dry 
matter contents from 24 to 31 %) was not convincingly demonstrated. 
DOCUMENTATION PROVIDED TO EFSA 
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3.  Evaluation  report  of  the  European  Union  Reference  Laboratory  for  Feed  Additives  on  the 
methods(s) of analysis for Bacillus amyloliquefaciens (NCIMB 30229) for all animal species. 
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APPENDIX 
Executive Summary of the Evaluation Report of the European Union Reference Laboratory for 
Feed Additives on the Method(s) of Analysis for Bacillus amyloliquefaciens (NCIMB 30229) for 
all animal species
19 
This report is on the evaluation of feed additives “micro-organisms used as silage agents”, which is 
related to the application of (1) forty two micro-organisms for which authorisation is sought under 
Article 10(2) and (2) three additional micro-organisms for which authorisation is sought under Article 
4(1). Authorisation is sought for all the above mentioned micro-organisms under category/functional 
group 1(k), technological additives/silage additives, according to Annex I of Regulation (EC) No 
1831/2003. The list of micro-organisms of interest and the minimum activities in the feed additives 
and in silage, as sought in the authorisation, are presented in Table 1.20 The intended use of the 
current applications is for all animal species, except for FAD-2011-0001, for which pigs, bovines, 
sheep, goats and horses are specified.  
For  identification  and  characterisation  of  Saccharomyces  cerevisiae  the  EURL  recommends  for 
official control Polymerase Chain Reaction (PCR), a generally recognised standard methodology for 
identification of yeasts. For identification and characterisation of all the other micro-organisms of 
concern  (i.e.  lactococci,  lactobacilli,  pediococci  and  bacilli)  the  EURL  recommends  for  official 
control Pulsed Field Gel Electrophoresis (PFGE), a generally recognised standard methodology for 
microbial identification. 
The  EURL  recommends  for  enumeration  in  the  feed  additives  the  following  ring  trial  validated 
methods: 
  Pour plate method using MRS agar (ISO 15214) for Lactococci;  
  Spread plate method using MRS agar (EN 15787) for Lactobacilli; 
  Spread plate method using MRS agar (EN 15786) for Pediococci; 
  Spread plate method using tryptone soya agar (EN 15784) for Bacilli; and  
  Pour plate method using CGYE agar (EN 15789) for Saccharomyces. 
None of the Applicants provide experimental data for the determination of micro-organisms in silage. 
Furthermore, the unambiguous determination of the content of micro-organisms added to silage is not 
achievable by analysis. Therefore the EURL cannot evaluate nor recommend any method for official 
control to determine any of the forty five micro-organisms of concern in silage. 
Further  testing  or  validation  of  the  methods to  be performed  through  the consortium  of  National 
Reference Laboratories as specified by article 10 (Commission Regulation (EC) No 378/2005) is not 
considered necessary. 
                                                       
19   The EURL produced a combined report for the L. lactis, L. plantarum, L. buchneri, L. paracasei, L. rhamnosus, L. 
salivarius, L. casei, L. brevis, L. pentosus, P. acidilactici, P. pentosaceus, Bacillus, Saccharomyces cerevisiae and 
Lactococcus lactis. 
20   Full list provided in EURL evaluation report, available from the EURL website: 
http://irmm.jrc.ec.europa.eu/SiteCollectionDocuments/FinRep-uorg-silage-group1.pdf 